Research On Risk Management Of Venture Capital In Biopharmaceutical Industry

Biological medicine industry is one of the fastest growing industry in the world trade,also be the most promising industry,biological medicine for human modern life has become increasingly important,make the pharmaceutical industry in the past 10 years has maintained a rapid growth trend.Prescription drugs,over-the-counter medicines and health care medicine is new trend for the future development of the pharmaceutical industry,the pharmaceutical industry is the future of three big emerging markets.But later in the biological medicine industry development in our country,the poor foundation,such as poor infrastructure,management consciousness weak,in all aspects need money,especially in technology research and development need of capital abnormal.Thus,the development of biological medicine industry in our country first solve the problem of financing,the financing is the core of risk management.Firstly,this paper analysis the connotation of risk investment and investment process of risk source,in describing the characteristics and the present situation of biological medicine industry in our country,on the basis of that risk investment market for rooted in biological pharmaceutical industry development in our country.Secondly,based on the theory and relevant method of risk investment,this paper set up evaluation index system of the risk of biological medicine industry in our country,and analysis in-depth the causes of failure of its relevant experience and enlightenment with the examples of HF company.Finally,this paper puts some suggestions on the risk investment project selection,design of agreement terms,risk mechanism and so on.These are not only help venture investors understand the market situation and characteristics of biological medicine industry in our country,but also alleviate the biological medicine industry in our country the financing difficult problem and realize the win-win result on both sides.